Zhengye Biotechnology Holding Limited (ZYBT)
NASDAQ: ZYBT · Real-Time Price · USD
1.140
0.00 (0.00%)
Jan 8, 2026, 4:00 PM EST - Market closed
ZYBT Employees
Zhengye Biotechnology Holding had 277 employees as of December 31, 2024. The number of employees decreased by 9 or -3.15% compared to the previous year.
Employees
277
Change (1Y)
-9
Growth (1Y)
-3.15%
Revenue / Employee
$77,473
Profits / Employee
-$9,760
Market Cap
54.03M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 277 | -9 | -3.15% |
| Dec 31, 2023 | 286 | -8 | -2.72% |
| Dec 31, 2022 | 294 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
ZYBT News
- 6 months ago - Zhengye Biotechnology Holding Limited Announces Fiscal Year 2024 Financial Results - PRNewsWire
- 8 months ago - Zhengye Biotechnology Holding Limited Receives NASDAQ Notice Related to Late Filing of Form 20-F - GlobeNewsWire
- 1 year ago - Zhengye Biotechnology Holding Limited Announces Full Exercise of Underwriters' Over-Allotment Option - GlobeNewsWire
- 1 year ago - U.S. IPO Weekly Recap: Flowco Launches First Major IPO Of 2025 As Smithfield, Others Join The Pipeline - Seeking Alpha
- 1 year ago - Zhengye Biotechnology Holding Limited Announces Closing of Initial Public Offering - GlobeNewsWire
- 1 year ago - Zhengye Biotechnology Holding Limited Announces Pricing of Initial Public Offering - GlobeNewsWire
- 2 years ago - Zhengye Biotechnology's Growth Slows As It Seeks U.S. IPO - Seeking Alpha